Welcome to CDC stacks | Considerations for use of serogroup B meningococcal (MenB) vaccines in oersons at increased risk - 61022 | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Considerations for use of serogroup B meningococcal (MenB) vaccines in oersons at increased risk
Filetype[PDF-269.18 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Serogroup B meningococcal vaccines booster doses : Work Group interpretation, considerations for policy options, and next steps
    Personal Author:
    Mbaeyi, Sarah A.
    Corporate Author:
    United States. Advisory Committee on Immunization Practices. Meningococcal Work Group.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
    Published:
    February 28, 2019
    Series:
    ACIP meeting Meningococcal Vaccines
    Description:
    Meningococcal-5-Mbaeyi-508.pdf
    File Type:
    Filetype[PDF - 259.64 KB]
  2. Serogroup B meningococcal vaccine booster doses
    Personal Author:
    Mbaeyi, Sarah A.
    Corporate Author:
    United States. Advisory Committee on Immunization Practices. Meningococcal Work Group.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27, 2019 : Atlanta, GA)
    Published:
    June 27, 2019
    Series:
    ACIP meeting Meningococcal Vaccines
    Description:
    Meningococcal-2-Mbaeyi-508.pdf
    File Type:
    Filetype[PDF - 615.05 KB]
  3. Considerations for serogroup B meningococcal (MenB) vaccine booster doses in persons at increased risk for serogroup B meningococcal disease
    Personal Author:
    MacNeil, Jessica
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Conference Author:
    National Center for Immunization and Respiratory Diseases (U.S.)
    Published:
    3/30/2017
    Series:
    ACIP meeting Meningococcal Vaccines
    Description:
    Presentations February 2017 Day : On the agenda, this presentation listed as: Considerations for MenB booster doses in groups at increased risk for serogroup B meningococcal disease : meningococcal-02-macneil.pdf
    File Type:
    Filetype[PDF - 621.70 KB]
  4. Epidemiology of meningococcal disease among college students – United States, 2014-2016
    Personal Author:
    Meyer, Sarah A.
    Corporate Author:
    National Center for Immunization and Respiratory Diseases (U.S.)
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
    Published:
    4/6/18
    Series:
    ACIP meeting Meningococcal Vaccines
    Description:
    Presentations February 2018 Day 2 : Publication date from document properties. : Mening-02-Meyer-508.pdf
    File Type:
    Filetype[PDF - 655.55 KB]
  5. Meningococcal Vaccines Work Group update
    Personal Author:
    Rubin, Lorry
    Corporate Author:
    United States. Advisory Committee on Immunization Practices. Meningococcal Vaccines Work Group.. National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases..
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2015 June 24-25 : Atlanta, GA)
    Published:
    June 24, 2015
    Series:
    ACIP meeting Meningococcal Vaccines
    File Type:
    Filetype[PDF - 126.41 KB]